|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
2
|
Choi IJ, Kook MC, Kim YI, Cho SJ, Lee JY,
Kim CG, Park B and Nam BH: Helicobacter pylori Therapy for the
Prevention of Metachronous Gastric Cancer. N Engl J Med.
378:1085–1095. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Greenberg ER, Anderson GL, Morgan DR,
Torres J, Chey WD, Bravo LE, Dominguez RL, Ferreccio C, Herrero R,
Lazcano-Ponce EC, et al: 14-day triple, 5-day concomitant, and
10-day sequential therapies for Helicobacter pylori infection in
seven Latin American sites: A randomised trial. Lancet.
378:507–514. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee YC, Chiang TH, Chou CK, Tu YK, Liao
WC, Wu MS and Graham DY: Association Between Helicobacter pylori
Eradication and Gastric Cancer Incidence: A Systematic Review and
Meta-analysis. Gastroenterology. 150:1113–1124, e5. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang F, Sun GP, Zou YF, Zhong F, Ma T, Li
XQ and Wu D: Helicobacter pylori infection predicts favorable
outcome in patients with gastric cancer. Curr Oncol. 20:e388–e395.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang F, Sun G, Zou Y, Zhong F, Ma T and Li
X: Protective role of Helicobacter pylori infection in prognosis of
gastric cancer: Evidence from 2,454 patients with gastric cancer.
PLoS One. 8:e624402013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zheng F, Sun Z, Kan J, Yin J, Du F, Shen
G, Wang Z, Ren D, Bao X and Zhao J: Is It a Protective Factor of
Helicobacter pylori Infection in Overall Survival of All Gastric
Cancer? Evidence from Meta-Analysis. J Environ Pathol Toxicol
Oncol. 36:309–320. 2017. View Article : Google Scholar
|
|
8
|
Varga MG, Wang T, Cai H, Xiang YB, Gao YT,
Ji BT, Pawlita M, Waterboer T, Zheng W, Shu XO, et al: Helicobacter
pylori Blood Biomarkers and Gastric Cancer Survival in China.
Cancer Epidemiol Biomarkers Prev. 27:342–344. 2018. View Article : Google Scholar
|
|
9
|
Malfertheiner P, Megraud F, O'Morain CA,
Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY,
Rokkas T, et al: European Helicobacter Study Group: Management of
Helicobacter pylori infection - the Maastricht IV/Florence
Consensus Report. Gut. 61:646–664. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Morgan DR, Torres J, Sexton R, Herrero R,
Salazar-Martínez E, Greenberg ER, Bravo LE, Dominguez RL, Ferreccio
C, Lazcano-Ponce EC, et al: Risk of recurrent Helicobacter pylori
infection 1 year after initial eradication therapy in 7 Latin
American communities. JAMA. 309:578–586. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nagai K, Davies TA, Jacobs MR and
Appelbaum PC: Effects of amino acid alterations in
penicillin-binding proteins (PBPs) 1a, 2b, and 2× on PBP affinities
of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime,
cefprozil, and cefaclor in 18 clinical isolates of
penicillin-susceptible, -intermediate, and -resistant pneumococci.
Antimicrob Agents Chemother. 46:1273–1280. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Polk DB and Peek RM Jr: Helicobacter
pylori: Gastric cancer and beyond. Nat Rev Cancer. 10:403–414.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Park JY, Forman D, Waskito LA, Yamaoka Y
and Crabtree JE: Epidemiology of Helicobacter pylori and
CagA-Positive Infections and Global Variations in Gastric Cancer.
Toxins (Basel). 10. pp. 102018, View Article : Google Scholar
|
|
14
|
Yong X, Tang B, Li BS, Xie R, Hu CJ, Luo
G, Qin Y, Dong H and Yang SM: Helicobacter pylori virulence factor
CagA promotes tumorigenesis of gastric cancer via multiple
signaling pathways. Cell Commun Signal. 13:302015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sokolova O, Borgmann M, Rieke C,
Schweitzer K, Rothkötter HJ and Naumann M: Helicobacter pylori
induces type 4 secretion system-dependent, but CagA-independent
activation of IκBs and NF-κB/RelA at early time points. Int J Med
Microbiol. 303:548–552. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yoon JH, Seo HS, Choi SS, Chae HS, Choi
WS, Kim O, Ashktorab H, Smoot DT, Nam SW, Lee JY, et al: Gastrokine
1 inhibits the carcinogenic potentials of Helicobacter pylori CagA.
Carcinogenesis. 35:2619–2629. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cadamuro AC, Rossi AF, Maniezzo NM and
Silva AE: Helicobacter pylori infection: Host immune response,
implications on gene expression and microRNAs. World J
Gastroenterol. 20:1424–1437. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Verma R and Sharma PC: Next generation
sequencing-based emerging trends in molecular biology of gastric
cancer. Am J Cancer Res. 8:207–225. 2018.PubMed/NCBI
|
|
19
|
Ueda T, Volinia S, Okumura H, Shimizu M,
Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, et al:
Relation between microRNA expression and progression and prognosis
of gastric cancer: A microRNA expression analysis. Lancet Oncol.
11:136–146. 2010. View Article : Google Scholar
|
|
20
|
Siu LK, Leung WK, Cheng AF, Sung JY, Ling
TK, Ling JM, Ng EK, Lau JY and Chung SC: Evaluation of a selective
transport medium for gastric biopsy specimens to be cultured for
Helicobacter pylor i. J Clin Microbiol. 36:3048–3050.
1998.PubMed/NCBI
|
|
21
|
Atrisco-Morales J, Martínez-Santos VI,
Román-Román A, Alarcón-Millán J, De Sampedro-Reyes J, Cruz-Del
Carmen I, Martínez-Carrillo DN and Fernández-Tilapa G: vacA s1m1
genotype and cagA EPIYA-ABC pattern are predominant among
Helicobacter pylori strains isolated from Mexican patients with
chronic gastritis. J Med Microbiol. 67:314–324. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kwon YH, Kim JY, Kim N, Park JH, Nam RH,
Lee SM, Kim JW, Kim JM, Park JY and Lee DH: Specific mutations of
penicillin-binding protein 1A in 77 clinically acquired
amoxicillin-resistant Helicobacter pylori strains in comparison
with 77 amoxicillin-susceptible strains. Helicobacter. 22:222017.
View Article : Google Scholar
|
|
23
|
Bisignano C, Filocamo A, La Camera E,
Zummo S, Fera MT and Mandalari G: Antibacterial activities of
almond skins on cagA-positive and-negative clinical isolates of
Helicobacter pylor i. BMC Microbiol. 13:1032013. View Article : Google Scholar
|
|
24
|
Qureshi NN, Gallaher B and Schiller NL:
Evolution of amoxicillin resistance of Helicobacter pylori in
vitro: Characterization of resistance mechanisms. Microb Drug
Resist. 20:509–516. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Al-Maleki AR, Loke MF, Lui SY, Ramli NSK,
Khosravi Y, Ng CG, Venkatraman G, Goh KL, Ho B and Vadivelu J:
Helicobacter pylori outer inflammatory protein A (OipA) suppresses
apoptosis of AGS gastric cells in vitro. Cell Microbiol. 19:192017.
View Article : Google Scholar
|
|
26
|
Yang J, Song H, Cao K, Song J and Zhou J:
Comprehensive analysis of Helicobacter pylori infection-associated
diseases based on miRNA-mRNA interaction network. Brief Bioinform.
Mar 20–2018.Epub ahead of print.
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
28
|
Yang Y, Li X, Du J, Yin Y and Li Y:
Involvement of microRNAs-MMPs-E-cadherin in the migration and
invasion of gastric cancer cells infected with Helicobacter pylor
i. Exp Cell Res. 367:196–204. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tsai KF, Liou JM, Chen MJ, Chen CC, Kuo
SH, Lai IR, Yeh KH, Lin MT, Wang HP, Cheng AL, et al: Taiwan
Gastrointestinal Disease and Helicobacter Consortium: Distinct
Clinicopathological Features and Prognosis of Helicobacter pylori
Negative Gastric Cancer. PLoS One. 12:e01709422017. View Article : Google Scholar
|
|
30
|
DeLoney CR and Schiller NL:
Characterization of an In vitro-selected amoxicillin-resistant
strain of Helicobacter pylor i. Antimicrob Agents Chemother.
44:3368–3373. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Paul R, Postius S, Melchers K and Schäfer
KP: Mutations of the Helicobacter pylori genes rdxA and pbp1 cause
resistance against metronidazole and amoxicillin. Antimicrob Agents
Chemother. 45:962–965. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gerrits MM, Schuijffel D, van Zwet AA,
Kuipers EJ, Vandenbroucke-Grauls CM and Kusters JG: Alterations in
penicillin-binding protein 1A confer resistance to beta-lactam
antibiotics in Helicobacter pylor i. Antimicrob Agents Chemother.
46:2229–2233. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liang L, Zeng M, Pan H, Liu H and He Y:
Nicotinamide N-methyltransferase promotes epithelial-mesenchymal
transition in gastric cancer cells by activating transforming
growth factor-β1 expression. Oncol Lett. 15:4592–4598.
2018.PubMed/NCBI
|
|
34
|
Polakovicova I, Jerez S, Wichmann IA,
Sandoval-Bórquez A, Carrasco-Véliz N and Corvalán AH: Role of
microRNAs and Exosomes in Helicobacter pylori and Epstein-Barr
Virus Associated Gastric Cancers. Front Microbiol. 9:6362018.
View Article : Google Scholar :
|
|
35
|
Li J, Wang Y, Luo J, Fu Z, Ying J, Yu Y
and Yu W: miR-134 inhibits epithelial to mesenchymal transition by
targeting FOXM1 in non-small cell lung cancer cells. FEBS Lett.
586:3761–3765. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu CJ, Shen WG, Peng SY, Cheng HW, Kao
SY, Lin SC and Chang KW: miR-134 induces oncogenicity and
metastasis in head and neck carcinoma through targeting WWOX gene.
Int J Cancer. 134:811–821. 2014. View Article : Google Scholar
|
|
37
|
Qin Q, Wei F, Zhang J and Li B: miR-134
suppresses the migration and invasion of non small cell lung cancer
by targeting ITGB1. Oncol Rep. 37:823–830. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zha R, Guo W, Zhang Z, Qiu Z, Wang Q, Ding
J, Huang S, Chen T, Gu J, Yao M, et al: Genome-wide screening
identified that miR-134 acts as a metastasis suppressor by
targeting integrin β1 in hepatocellular carcinoma. PLoS One.
9:e876652014. View Article : Google Scholar
|
|
39
|
Liu Y, Zhang M, Qian J, Bao M, Meng X,
Zhang S, Zhang L, Zhao R, Li S, Cao Q, et al: miR-134 functions as
a tumor suppressor in cell proliferation and
epithelial-to-mesenchymal Transition by targeting KRAS in renal
cell carcinoma cells. DNA Cell Biol. 34:429–436. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pan JY, Zhang F, Sun CC, Li SJ, Li G, Gong
FY, Bo T, He J, Hua RX and Hu WD: miR-134: A Human Cancer
Suppressor? Mol Ther Nucleic Acids. 6:140–149. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Korver W, Roose J and Clevers H: The
winged-helix transcription factor Trident is expressed in cycling
cells. Nucleic Acids Res. 25:1715–1719. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li Q, Zhang N, Jia Z, Le X, Dai B, Wei D,
Huang S, Tan D and Xie K: Critical role and regulation of
transcription factor FoxM1 in human gastric cancer angiogenesis and
progression. Cancer Res. 69:3501–3509. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ma J, Qi G, Xu J, Ni H, Xu W, Ru G, Zhao
Z, Xu W and He X: Overexpression of forkhead box M1 and
urokinase-type plasminogen activator in gastric cancer is
associated with cancer progression and poor prognosis. Oncol Lett.
14:7288–7296. 2017.
|
|
45
|
Yang L, Cui M, Zhang L and Song L: FOXM1
facilitates gastric cancer cell migration and invasion by inducing
Cathepsin D. Oncotarget. 8:68180–68190. 2017.PubMed/NCBI
|
|
46
|
Zhang J, Chen XY, Huang KJ, Wu WD, Jiang
T, Cao J, Zhou LS, Qiu ZJ and Huang C: Expression of FoxM1 and the
EMT-associated protein E-cadherin in gastric cancer and its
clinical significance. Oncol Lett. 12:2445–2450. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yu H, Shen Y, Hong J, Xia Q, Zhou F and
Liu X: The contribution of TGF-β in Epithelial-Mesenchymal
Transition (EMT): Down-regulation of E-cadherin via snail.
Neoplasma. 62:1–15. 2015. View Article : Google Scholar
|
|
48
|
Feng Y, Wang L, Zeng J, Shen L, Liang X,
Yu H, Liu S, Liu Z, Sun Y, Li W, et al: FoxM1 is overexpressed in
Helicobacter pylori-induced gastric carcinogenesis and is
negatively regulated by miR-370. Mol Cancer Res. 11:834–844. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Gunawardhana N, Jang S, Choi YH, Hong YA,
Jeon YE, Kim A, Su H, Kim JH, Yoo YJ, Merrell DS, et al:
Helicobacter pylori-Induced HB-EGF Upregulates Gastrin Expression
via the EGF Receptor, C-Raf, Mek1, and Erk2 in the MAPK Pathway.
Front Cell Infect Microbiol. 7:5412018. View Article : Google Scholar :
|
